Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis

The interactions of CD28‐B7 and CD40‐CD40 ligand (CD40L) pathways in T cell co‐stimulation and autoimmune disease are incompletely understood. We sought to address this issue by investigation of the genesis of acetylcholine receptor (AChR)‐induced antibody‐mediated experimental autoimmune myasthenia...

Full description

Saved in:
Bibliographic Details
Published in:European journal of immunology Vol. 28; no. 11; pp. 3587 - 3593
Main Authors: Shi, Fu‐Dong, He, Bing, Li, Hulun, Matusevicius, Darius, Link, Hans, Ljunggren, Hans‐Gustaf
Format: Journal Article
Language:English
Published: Weinheim WILEY‐VCH Verlag GmbH 01-11-1998
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The interactions of CD28‐B7 and CD40‐CD40 ligand (CD40L) pathways in T cell co‐stimulation and autoimmune disease are incompletely understood. We sought to address this issue by investigation of the genesis of acetylcholine receptor (AChR)‐induced antibody‐mediated experimental autoimmune myasthenia gravis (EAMG) in CD28‐ and CD40L‐deficient mice (CD28− / − , CD40L− / − ). Compared to wild‐type mice, the CD28− / − mice became less susceptible, and CD40L− / − mice were completely resistant to EAMG induction. Analysis of T helper functions, reflected by cytokine responses, revealed a switch to a Th1 profile in CD28− / − mice. Consistently, levels of serum AChR‐specific antibodies of the IgG1 isotype were decreased in CD28− / − mice. In the CD40L− / − mice, both Th1 and Th2 cytokine responses were diminished, and T cell‐dependent AChR‐reactive B cell responses were more severely impaired than in the CD28− / − mice. Thus, CD28 and CD40L are differentially required for induction of EAMG.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-2980
1521-4141
DOI:10.1002/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y